Wall Street RegretsThe regret calculator.

What if you'd held CLRB?

A $1,000 investment in Cellectar Biosciences, Inc. (CLRB) at the month-end close of 2005-11 would be worth $0.00000771 at the close of 2026-09 — -100.0% total return, dividends reinvested. The same $1,000 in the S&P 500, dividends reinvested, would be worth $9,166.

$1,000 since 2005$0.00000771Total return-100.0%Multiple0.00×CAGR-59.2%

Your scenario

Dates resolve to the nearest month-end close.
Leave empty for "held until today".
Invested at each month-end. Starts on the buy date.

Result

Worth$0.00000771Gain+$-1,000 (-100.0%)Multiple0.0×CAGR-59.2%

    If you'd bought $1,000 at the start of each year

    Value of $1,000 invested on January 1 of each year, held to 2026-09, dividends included.

    2005$0.000007712006$0.000012912007$0.000029672008$0.000043762009$0.000054932010$0.000010242011$0.00086062012$0.0089772013$0.0053382014$0.012015$0.032016$0.112017$0.652018$0.582019$5.102020$3.512021$3.802022$11.972023$46.202024$28.522025$2632026$803

    Every year, $1,000 from 2005

    YearValue of $1,000Year return
    2005$1,000
    2006$435-56.5%
    2007$295-32.2%
    2008$235-20.3%
    2009$1,260+436.2%
    2010$15.00-98.8%
    2011$1.44-90.4%
    2012$2.42+68.2%
    2013$1.21-50.0%
    2014$0.50-58.2%
    2015$0.12-76.1%
    2016$0.02-83.5%
    2017$0.02+12.3%
    2018$0.002533-88.7%
    2019$0.003676+45.2%
    2020$0.003399-7.6%
    2021$0.001078-68.3%
    2022$0.0002794-74.1%
    2023$0.0004526+62.0%
    2024$0.00004902-89.2%
    2025$0.00001607-67.2%
    2026$0.00001291-19.7%

    Best and worst month-end to buy

    The best single month-end close to have bought CLRB was 2026-09 ($2.37): $1,000 then is $1,000 today. The worst was 2005-11 ($307.53M): $1,000 then is $0.00000771.

    FAQ

    What would $1,000 in CLRB be worth today?

    A $1,000 investment in Cellectar Biosciences, Inc. (CLRB) at the start of 2005 would be worth about $0.00000771 today, a total return of -100.0%. Dividends are reinvested in these figures.

    What were the best and worst years for CLRB?

    Cellectar Biosciences, Inc. (CLRB)'s strongest calendar year since 2005 was 2009, a +436.2% return — $1,000 held through that year became about $5,362 by year-end. Its weakest year was 2010, at -98.8%.

    Does the calculator include dividends and splits?

    Yes where available. Prices are adjusted for both stock splits and reinvested dividends (total return), the same measure brokerages use.

    How much would $100 per month in CLRB have grown?

    Investing $100 at the end of every month since 2005-11 would have grown to about $1,477 on $25,100 invested.

    Did CLRB beat the S&P 500?

    Over the same period, $1,000 in the S&P 500 with dividends reinvested (the S&P 500 Total Return index) would be worth $9,166. CLRB trailed the S&P 500 by +100.0% in total return.

    Is this investment advice?

    No. Wall Street Regrets is an entertainment and education tool. Every number is a historical calculation, not a prediction, and past performance never guarantees future results.

    Methodology

    Cellectar Biosciences, Inc. (CLRB) historical total-return data from 2005-11 to 2026-09, reduced to month-end closes for the tables above.

    Returns use adjusted close prices — adjusted for stock splits and reinvested dividends, the same convention used by major brokerages. End-of-day and live prices come from EODHD; parts of the deep historical series are carried over from Yahoo Finance data. A "year" scenario invests $1,000 at the prior December's month-end close and values it at the latest available month-end close. Non-USD amounts are converted at historical month-end exchange rates (EODHD): to USD on the buy date and back to your currency at the latest rate, so the return reflects the currency move as well as the asset.

    Month-end resolution means intra-month extremes are not captured in tables; the calculator uses exact trading-day closes where daily data is available. Figures ignore taxes, fees, and the currency effects of non-USD listings. History is not a forecast. Wall Street Regrets is entertainment, not investment advice.

    Full methodology →

    What if you'd held…

    Data: adjusted close prices via EODHD and Yahoo Finance. As of 2026-09-04. Not financial advice.